paroxysmal nocturnal hemoglobinurea

Clinical Manifestation and Errors in the Diagnosis of Classical Paroxysmal Nocturnal Hemoglobinuria: A clinical case series of 150 patients

RARE HEMATOLOGICAL TUMORS AND SYNDROMES , , , ,

AD Kulagin, OU Klimova, AV Dobronravov, MO Ivanova, TA Rudakova, EV Babenko, VA Dobronravov, BV Afanas’ev

Pavlov First Saint Petersburg State Medical University, 6/8 L’va Tolstogo str., Saint Petersburg, Russian Federation, 197022

For correspondence: Aleksander Dmitrievich Kulagin, DSci, 6/8 L’va Tolstogo str., Saint Petersburg, Russian Federation, 197022; Теl.: +7(812)338-62-36; e-mail: kulagingem@rambler.ru

For citation: Kulagin AD, Klimova OU, Dobronravov AV, et al. Clinical Manifestation and Errors in the Diagnosis of Classical Paroxysmal Nocturnal Hemoglobinuria: A clinical case series of 150 patient. Clinical oncohematology. 2017;10(3):333–41 (In Russ).

DOI: 10.21320/2500-2139-2017-10-3-333-341

ABSTRACT

Background. Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal disease of the blood system, characterized by intravascular hemolysis, cytopenia and thrombosis. Diagnostic errors with delayed diagnosis of PNH are often due to the variety of the clinical presentation and the lack of awareness of the doctors of this rare disease.

Aim. The aim of the study was to characterize the options for clinical manifestation and the complexity of diagnosis of classical PNH.

Materials & Methods. The research included 150 patients with PNH. The inclusion criteria were: 1) clinical and laboratory signs of intravascular hemolysis; 2) verification of the diagnosis using standard flow cytometry; 3) absence of aplastic anemia, myelodysplastic syndrome and primary myelofibrosis. The patients were of 13 to 72 years old (median age 34 years). The study population consisted of 89 (59 %) women and 61 (41 %) men.

Results. The time before the diagnosis ranged from 0 to 455 months (median 33 months). The median size of the PNH clone among granulocytes and erythrocytes was 95 % and 41 %, respectively. The median of the lactic dehydrogenase was 7.2 times the upper limit of normal (ULN). Cytopenia occurred in 65 % of patients, including a combination of thrombocytopenia and neutropenia in 29 % of cases. Weakness and fatigue (99 %), hemoglobinuria (57 %), pain (52 %), icterus (46 %), dysphagia (37 %) and infection/fever (23 %) were the most common symptoms on the onset of the disease. Before the diagnosis of PNH, thrombosis or acute kidney injury was found in 22 % and 18 % of patients, respectively. Only 22 % of patients were initially diagnosed with PNH. In the remaining patients, the primary diagnosis was inadequate.

Conclusion. The clinical manifestation of PNH is characterised by the presence of hemoglobinuria, cytopenia and early thrombosis in 57 %, 65 % and 22 % of patients, respectively. Errors of the primary diagnosis reach 78 % and lead to inadequate treatment. The results of the research showed the need for multidisciplinary approach and strict adherence to diagnostic algorithms of PNH in the risk groups, according to current recommendations.

Keywords: paroxysmal nocturnal hemoglobinurea, PNH clone, cytopenia, clinical manifestation, diagnostic errors.

Received: February 20, 2017

Accepted: May 8, 2017

Read in PDF (RUS)pdficon

REFERENCES

  1. Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73(4):703–11. doi: 10.1016/0092-8674(93)90250-T.
  2. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293(13):1653–62. doi: 10.1001/jama.293.13.1653.
  3. Parker C, Omine M, Richards S, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106(12):3699–709. doi: 10.1182/blood-2005-04-1717.
  4. Hillmen P, Lewis SM, Bessler M, et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995;333(19):1253–8. doi: 10.1056/NEJM199511093331904.
  5. Socie G, Mary JY, de Gramont A, et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet. 1996;348(9027):573–7. doi: 10.1016/S0140-6736(95)12360-1.
  6. Кулагин А.Д., Лисуков И.А., Птушкин В.В. и др. Национальные клинические рекомендации по диагностике и лечению пароксизмальной ночной гемоглобинурии. Онкогематология. 2014;9(2):20–8. doi: 10.17650/1818-8346-2014-9-2-20-28.
    [Kulagin AD, Lisukov IA, Ptushkin VV, et al. National clinical guidelines for the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria. Oncohematology. 2014;9(2):20–8. doi: 10.17650/1818-8346-2014-9-2-20-28. (In Russ)]
  7. Dacie IV, Lewis SM. Paroxysmal nocturnal hemoglobinuria: clinical manifestation, haematology, and nature of the disease. Series Haematol. 1972;5(3):3–23.
  8. Nishimura J, Kanakura Y, Ware RE, et al. Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine (Baltimore). 2004;83(3):193–207. doi: 10.1097/01.md.0000126763.68170.46.
  9. de Latour RP, Mary JY, Salanoubat C, et al. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood. 2008;112(8):3099–106. doi: 10.1182/blood-2008-01-133918.
  10. Ge M, Li X, Shi J, et al. Clinical features and prognostic factors of Asian patients with paroxysmal nocturnal hemoglobinuria: results from a single center in China. Ann Hematol. 2012;91(7):1121–8. doi: 10.1007/s00277-012-1413-6.
  11. Гаврилов О.К., Файнштейн Ф.Э., Турбина Н.С. Депрессии кроветворения. М.: Медицина, 1987. 256 c.
    [Gavrilov OK, Fainshtein FE, Turbina NS. Depressii krovetvorenia. (Hematopoiesis depressions.) Moscow: Meditsina Publ.; 1987. 256 p. (In Russ)]
  12. Moyo VM, Mukhina GL, Garrett ES, Brodsky RA. Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays. Br J Haematol. 2004;126(1):133–8. doi: 10.1111/j.1365-2141.2004.04992.x.
  13. Schrezenmeier H, Muus P, Socie G, et al. Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica. 2014;99(5):922–9. doi: 10.3324/haematol.2013.093161.
  14. Kulagin A, Lisukov I, Ivanova M, et al. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study. Br J Haematol. 2014;164(4):546–54. doi: 10.1111/bjh.12661.
  15. Kulagin A, Golubovskaya I, Ivanova M, et al. Incidence and risk factors for hemolytic paroxysmal nocturnal hemoglobinuria (PNH) in aplastic anemia (AA) patients. Bone Marrow Transplant. 2014;49(Suppl 1):S42–3. doi: 10.1038/bmt.2014.43.
  16. Sipol AA, Babenko EV, Borisov VI, et al. An inter-laboratory comparison of PNH clone detection by high-sensitivity flow cytometry in a Russian cohort. Hematology. 2015;20(1):31–8. doi: 10.1179/1607845414Y.0000000162.
  17. Kim JS, Jang JH, Yoon SS, et al. Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry. Ann Hematol. 2016;95(1):125–33. doi: 10.1007/s00277-015-2511-z.
  18. Yu F, Du Y, Han B. A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe/America. Int J Hematol. 2016;103(6):649–54. doi: 10.1007/s12185-016-1995-1.
  19. Kulagin A, Klimova O, Dobronravov A, et al. Incidence, clinical characteristics and outcome of symptomatic thromboembolic events (TE) in 276 patients with paroxysmal nocturnal hemoglobinurea (PNH). Blood (ASH Annual Meeting Abstracts). 2016;128(22):5072.
  20. Richani K, Soto E, Romero R, et al. Normal pregnancy is characterized by systemic activation of the complement system. J Mat Fet Neonat Med. 2005;17(4):239–45. doi: 10.1080/14767050500072722.
  21. de Guibert S, de Latour RP, Varoqueaux N, et al. Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience. Haematologica. 2011;96(9):1276–83. doi: 10.3324/haematol.2010.037531.
  22. Nakao S. Diagnostic problems in acquired bone marrow failure syndromes. Int J Hematol. 2016;104(2):151–2. doi: 10.1007/s12185-016-2057-4.